| LYRA |
Lyra Therapeutics, Inc. |
09 Dec 2024 |
1 |
$0 |
4 |
Executive Chair, Director |
11 Dec 2024, 18:39 |
| PCSC |
Perceptive Capital Solutions Corp |
11 Jun 2024 |
0 |
$0 |
3 |
Director |
11 Jun 2024, 17:52 |
| LYRA |
Lyra Therapeutics, Inc. |
18 Mar 2024 |
1 |
$0 |
4 |
Executive Chair, Director |
20 Mar 2024, 19:21 |
| LYRA |
Lyra Therapeutics, Inc. |
10 Nov 2023 |
1 |
+$74,095 |
4 |
Executive Chair, Director |
13 Nov 2023, 17:29 |
| LYRA |
Lyra Therapeutics, Inc. |
31 Jan 2023 |
1 |
$0 |
4 |
Executive Chair, Director |
02 Feb 2023, 16:19 |
| LYRA |
Lyra Therapeutics, Inc. |
16 Jun 2022 |
1 |
$0 |
4 |
Executive Chair, Director |
21 Jun 2022, 16:06 |
| LYRA |
Lyra Therapeutics, Inc. |
12 Apr 2022 |
1 |
+$999,997 |
4 |
Executive Chair, Director |
13 Apr 2022, 19:16 |
| LYRA |
Lyra Therapeutics, Inc. |
16 Feb 2022 |
1 |
$0 |
4 |
Executive Chair, Director |
18 Feb 2022, 16:09 |
| LYRA |
Lyra Therapeutics, Inc. |
16 Feb 2022 |
0 |
$0 |
3 |
Executive Chair, Director |
18 Feb 2022, 16:08 |
| /report/000110465921136412-waksal-harlan-2021-11-09 |
Kadmon Holdings, Inc. |
09 Nov 2021 |
6 |
+$25,797,748 |
4 |
President, CEO, Director |
09 Nov 2021, 16:42 |
| /report/000159396821001330-waksal-harlan-2021-05-13 |
Kadmon Holdings, Inc. |
13 May 2021 |
1 |
+$88,978 |
4 |
President, CEO, Director |
17 May 2021, 16:05 |